HLA Association with Drug-Induced Adverse Reactions.

about

HLA Association with Drug-Induced Adverse Reactions.

Item

http://www.wikidata.org/entity/Q47553722

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HLA Association with Drug-Induced Adverse Reactions.

@en

HLA Association with Drug-Induced Adverse Reactions.

@nl

type

Item

label

HLA Association with Drug-Induced Adverse Reactions.

@en

HLA Association with Drug-Induced Adverse Reactions.

@nl

prefLabel

HLA Association with Drug-Induced Adverse Reactions.

@en

HLA Association with Drug-Induced Adverse Reactions.

@nl

P1476

HLA Association with Drug-Induced Adverse Reactions

@en

P2093

Chuang-Wei Wang

http://www.w3.org/2001/XMLSchema#string

Meng-Shin Shiao

http://www.w3.org/2001/XMLSchema#string

Rosaline Chung-Yee Hui

http://www.w3.org/2001/XMLSchema#string

Wen-Lang Fan

http://www.w3.org/2001/XMLSchema#string

Ya-Ching Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity

Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Medical genetics: a marker for Stevens-Johnson syndrome

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

HLA association of amoxicillin-clavulanate--induced hepatitis

Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care

P304

3186328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3186328

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Shih-Chi Su

Wen-Hung Chung

P577

2017-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29333460

http://www.w3.org/2001/XMLSchema#string

P932

5733150

http://www.w3.org/2001/XMLSchema#string